<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · India</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to India.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/countries/in.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Multistakeholder Consultations on Programmatic Progress, Challenges, and Policy Priorities for Lymphatic Filariasis Elimination in India</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-4269-ajtmh-26-0054-7a6f8f75/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-4269-ajtmh-26-0054-7a6f8f75/</guid>
    <pubDate>Thu, 27 Aug 2026 00:00:00 GMT</pubDate>
    <description>The synthesized recommendations supply practical frameworks for adjusting national control campaigns, optimizing funding deployment, and mitigating structural impediments that delay disease clearance objectives.</description>
    <category>Filariasis</category>
    <category>Health policy</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Diagnostic yield of thoracoscopic pleural biopsy in undiagnosed exudative pleural effusion and comparative analysis of pleural fluid adenosine deaminase levels.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-4081-monaldi-2026-3910-98b83776/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-4081-monaldi-2026-3910-98b83776/</guid>
    <pubDate>Tue, 25 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings underscore a viable procedural pathway for resolving diagnostically ambiguous pleural conditions in regions where infectious and neoplastic respiratory diseases carry substantial prevalence.</description>
    <category>Tuberculosis</category>
    <category>Diagnostics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Melioidosis in South Asia: Scientific Advances, Regional Challenges and One Health Perspectives—An Integrated Research Synthesis from the 4th South Asian Melioidosis Congress</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-12688-wellcomeopenres-27378-1-ded6c4b1/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-12688-wellcomeopenres-27378-1-ded6c4b1/</guid>
    <pubDate>Fri, 21 Aug 2026 00:00:00 GMT</pubDate>
    <description>The compilation frames melioidosis as an escalating yet frequently ignored infectious threat that demands improved monitoring frameworks, uniform testing standards, and interdisciplinary coordination to decrease adverse health outcomes.</description>
    <category>Melioidosis</category>
    <category>Tuberculosis</category>
    <category>One Health</category>
    <category>Surveillance</category>
    <category>Outbreak investigation</category>
    <category>Antimicrobial resistance</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>The emergence of putative epistatic mutations and iSNVs in SARS-CoV-2 XBB.1.16 variants linked with alteration in immunogenic determinants</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3389-fimmu-2026-1846973-b86af0be/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3389-fimmu-2026-1846973-b86af0be/</guid>
    <pubDate>Thu, 20 Aug 2026 00:00:00 GMT</pubDate>
    <description>The work addresses how putative epistatic spike mutations in XBB.1.16 may contribute to immune evasion and variant dominance, relevant to understanding SARS-CoV-2 evolutionary trajectories.</description>
    <category>SARS</category>
    <category>COVID-19</category>
    <category>Vaccination</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Hidden burden of malaria in pregnancy in hard-to-reach areas of Odisha, India: challenges to elimination and the case for integrating molecular surveillance</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3389-fpubh-2026-1862569-615b5e80/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3389-fpubh-2026-1862569-615b5e80/</guid>
    <pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate>
    <description>Undetected parasitic carriage among expectant mothers complicates regional disease eradication initiatives. Integrating advanced diagnostic capabilities into routine antenatal monitoring could improve intervention targeting and support national health objectives.</description>
    <category>Malaria</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Diagnostics</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>Rheumatic fever/rheumatic heart disease, contemporary concepts, emerging paradigms and Indian perspective</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-4103-ijoc-ijoc-14-26-798038bf/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-4103-ijoc-ijoc-14-26-798038bf/</guid>
    <pubDate>Sat, 08 Aug 2026 00:00:00 GMT</pubDate>
    <description>Strengthening regional health infrastructure through coordinated diagnostic expansion and reliable medication supply chains is highlighted as essential for reducing ongoing morbidity.</description>
    <category>Rheumatic fever</category>
    <category>Surveillance</category>
    <category>Diagnostics</category>
    <category>Commentary</category>
  </item>
  <item>
    <title>Unravelling the genomic epidemiology and antigenic evolution of Chandipura virus: A genetically constrained neurotropic threat</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0014565-b79ade7a/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0014565-b79ade7a/</guid>
    <pubDate>Mon, 03 Aug 2026 00:00:00 GMT</pubDate>
    <description>Antigenic variations identified in key viral proteins indicate possible challenges for existing diagnostic assays and immunization platforms, reinforcing the value of continuous genomic tracking for health planning.</description>
    <category>Japanese Encephalitis</category>
    <category>Rabies</category>
    <category>Genomic epidemiology</category>
    <category>Surveillance</category>
    <category>Outbreak investigation</category>
    <category>Vaccination</category>
    <category>Diagnostics</category>
    <category>Genomic study</category>
  </item>
  <item>
    <title>A multicenter prospective observational multi-omics study protocol to identify biomarkers for severe dengue: COMBAT study clinical protocol</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-14111-x-4d3b66e8/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-14111-x-4d3b66e8/</guid>
    <pubDate>Fri, 31 Jul 2026 00:00:00 GMT</pubDate>
    <description>If biomarkers are successfully identified, findings may inform improved patient triage, early intervention strategies, and novel therapeutic targets for dengue management in endemic regions.</description>
    <category>Dengue</category>
    <category>Surveillance</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Comparison of the treatment outcomes and identification of the risk factors associated with unfavorable outcomes among extra pulmonary and pulmonary tuberculosis patients under NTEP</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13544-8-b33c8c7c/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13544-8-b33c8c7c/</guid>
    <pubDate>Fri, 12 Jun 2026 00:00:00 GMT</pubDate>
    <description>Documenting these outcome variations assists program administrators in refining case management strategies and prioritizing access to rapid microbiological verification and resistance screening tools.</description>
    <category>Tuberculosis</category>
    <category>Treatment</category>
    <category>Diagnostics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Outbreak investigation of reemerging chikungunya virus in Malaysia in 2019–2020</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13793-7-f951a548/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13793-7-f951a548/</guid>
    <pubDate>Thu, 11 Jun 2026 00:00:00 GMT</pubDate>
    <description>Tracking these adapted viral lineages helps clarify regional transmission pathways and highlights potential shifts in pathogen behavior affecting community health planning.</description>
    <category>Chikungunya</category>
    <category>Dengue</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Genomic epidemiology</category>
    <category>Genomic study</category>
  </item>
  <item>
    <title>Risk factors for post-kala-azar dermal leishmaniasis (PKDL): Challenges in understanding pathophysiology</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0013952-7b81c20d/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0013952-7b81c20d/</guid>
    <pubDate>Mon, 23 Feb 2026 00:00:00 GMT</pubDate>
    <description>The authors emphasize the need to integrate PKDL management within broader skin disease programs and to optimize VL treatment (e.g., multidrug regimens, immune modifiers) to potentially reduce PKDL incidence.</description>
    <category>Leishmaniasis</category>
    <category>Kala-azar</category>
    <category>Treatment</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Resurgent threat in a changing climate: A 20-year bibliometric analysis of global Chikungunya research evolution and pandemic preparedness</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0013959-55800fc0/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0013959-55800fc0/</guid>
    <pubDate>Mon, 23 Feb 2026 00:00:00 GMT</pubDate>
    <description>Highlights increasing academic investment in vaccine platforms and climate-linked transmission models. Identifies structural imbalances in multinational research partnerships and recommends aligning pathogen readiness initiatives with broader environmental health planning.</description>
    <category>Chikungunya</category>
    <category>COVID-19</category>
    <category>Dengue</category>
    <category>Climate and environment</category>
    <category>Surveillance</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Diagnostics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Addressing multimorbidity in Leprosy: A retrospective chart review from India</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0013503-cf164e48/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0013503-cf164e48/</guid>
    <pubDate>Tue, 17 Feb 2026 00:00:00 GMT</pubDate>
    <description>Results highlight the necessity for coordinated screening initiatives and adaptable care frameworks to manage overlapping health burdens within this marginalized demographic.</description>
    <category>Leprosy</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Avian influenza overview June-September 2025.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2903-j-efsa-2025-9702-e49d9870/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2903-j-efsa-2025-9702-e49d9870/</guid>
    <pubDate>Mon, 27 Oct 2025 00:00:00 GMT</pubDate>
    <description>The data indicate that routine community exposure poses minimal threat, though individuals with professional or environmental contact with infected fauna face a marginally higher probability of contracting the virus.</description>
    <category>Influenza</category>
    <category>H5N1</category>
    <category>Travel medicine</category>
    <category>One Health</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Impact of the indigenous rotavirus vaccine Rotavac in the Universal Immunization Program in India during 2016–2020</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-s41591-025-03998-9-b96e01f9/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-s41591-025-03998-9-b96e01f9/</guid>
    <pubDate>Tue, 07 Oct 2025 00:00:00 GMT</pubDate>
    <description>Findings from the abstract suggest Rotavac provided substantial protection against severe rotavirus disease under programmatic conditions in India, including against non-vaccine strains, and was characterized as performing comparably to internationally licensed vaccines in similar settings.</description>
    <category>Gastroenteritis</category>
    <category>SARS</category>
    <category>COVID-19</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Surveillance</category>
    <category>Case-control study</category>
  </item>
  <item>
    <title>Spatiotemporal epidemiology and clinical manifestations of two decades of scrub typhus in India: a systematic review and meta-analysis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1136-bmjgh-2025-018998-4a28d10f/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1136-bmjgh-2025-018998-4a28d10f/</guid>
    <pubDate>Sun, 03 Aug 2025 00:00:00 GMT</pubDate>
    <description>The abstract frames scrub typhus as an increasing public health concern in India and indicates that its geographic and temporal patterns may inform management and control policy. It also notes that addressing the reported upsurge may require an interdisciplinary public health approach.</description>
    <category>Typhus</category>
    <category>Scrub Typhus</category>
    <category>Transmission dynamics</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Health policy</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Avian influenza overview March-June 2025.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2903-j-efsa-2025-9520-80483e0c/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2903-j-efsa-2025-9520-80483e0c/</guid>
    <pubDate>Wed, 23 Jul 2025 00:00:00 GMT</pubDate>
    <description>Human infections with currently circulating avian A(H5) clade 2.3.4.4b viruses remain rare despite widespread animal circulation; the assessed EU/EEA risk is low for the general public and low-to-moderate for those with occupational exposure to infected animals or contaminated environments.</description>
    <category>Influenza</category>
    <category>H5N1</category>
    <category>Gastroenteritis</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>SARS-CoV-2 Alchemy: Understanding the dynamics of age, vaccination, and geography in the evolution of SARS-CoV-2 in India</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0012918-b8a344cd/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0012918-b8a344cd/</guid>
    <pubDate>Mon, 10 Mar 2025 00:00:00 GMT</pubDate>
    <description>The paper presents characterization of viral substitution patterns across demographic, geographic, and vaccination-period categories as relevant to ongoing monitoring of SARS-CoV-2 evolution and pandemic preparedness. These implications are based on the study&apos;s reported genomic patterns and do not establish causal effects or confirm a current surveillance signal.</description>
    <category>SARS</category>
    <category>COVID-19</category>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Seasonal influenza surveillance and vaccination policies in the WHO South-East Asian Region</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1136-bmjgh-2024-017271-e18bdecd/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1136-bmjgh-2024-017271-e18bdecd/</guid>
    <pubDate>Wed, 12 Feb 2025 00:00:00 GMT</pubDate>
    <description>The region&apos;s high population density and role as a potential epicenter for future influenza pandemics makes comprehensive vaccination and surveillance policies critical for pandemic preparedness. Low vaccine uptake and limited surveillance data hinder effective public health responses across most SEAR countries.</description>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Surveillance</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Updating estimates of Plasmodium knowlesi malaria risk in response to changing land use patterns across Southeast Asia</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0011570-4d3af13f/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0011570-4d3af13f/</guid>
    <pubDate>Mon, 22 Jan 2024 00:00:00 GMT</pubDate>
    <description>The findings may help inform geographic prioritization for P. knowlesi diagnosis, treatment planning, surveillance and sampling, as described by the authors. The abstract also places the work in the context of malaria elimination planning.</description>
    <category>Malaria</category>
    <category>Climate and environment</category>
    <category>Transmission dynamics</category>
    <category>Surveillance</category>
    <category>Treatment</category>
    <category>One Health</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for an inactivated viral vaccine against Chikungunya virus</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2022-06-006-6f3ef0e0/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2022-06-006-6f3ef0e0/</guid>
    <pubDate>Mon, 01 Aug 2022 00:00:00 GMT</pubDate>
    <description>Inactivated viral vaccine technology has been applied to diseases of global health threat, and this chikungunya vaccine candidate offers an effective, flexible system for high-yield manufacturing with favorable stability for distribution.</description>
    <category>Chikungunya</category>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Poliomyelitis</category>
    <category>Influenza</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Vaccine safety</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>The current burden of Japanese encephalitis and the estimated impacts of vaccination: Combining estimates of the spatial distribution and transmission intensity of a zoonotic pathogen</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0009385-0e69e500/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0009385-0e69e500/</guid>
    <pubDate>Wed, 13 Oct 2021 00:00:00 GMT</pubDate>
    <description>The estimates identify countries and populations where the authors project that increased vaccination coverage could have a substantial effect on Japanese encephalitis burden. The abstract also indicates that reported cases and deaths are substantially below the estimated burden in many endemic countries.</description>
    <category>Japanese Encephalitis</category>
    <category>Vaccination</category>
    <category>Transmission dynamics</category>
    <category>One Health</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Disease surveillance during a large religious mass gathering in India: The Prayagraj Kumbh 2019 experience</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2020-09-1424-021d8b0e/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2020-09-1424-021d8b0e/</guid>
    <pubDate>Tue, 01 Dec 2020 00:00:00 GMT</pubDate>
    <description>The article indicates that incorporating onsite surveillance into mass-gathering planning can support detection, verification, and response to reported disease signals. It identifies acute respiratory illness as a leading reported morbidity category and recommends strengthening its diagnosis and management capacity for future mass gatherings.</description>
    <category>Gastroenteritis</category>
    <category>Surveillance</category>
    <category>Travel medicine</category>
    <category>Outbreak investigation</category>
    <category>Climate and environment</category>
    <category>Vaccination</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Costs incurred by patients with drug-susceptible pulmonary tuberculosis in semi-urban and rural settings of Western India</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s40249-020-00760-w-a3ed3fc3/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s40249-020-00760-w-a3ed3fc3/</guid>
    <pubDate>Mon, 19 Oct 2020 00:00:00 GMT</pubDate>
    <description>While treatment completion rates were high and patient costs were relatively low, negative financial consequences—including catastrophic costs, borrowing, and job loss—persisted even in this low-cost setting, indicating potential benefit from universal cash transfer programs.</description>
    <category>Tuberculosis</category>
    <category>Climate and environment</category>
    <category>Treatment</category>
    <category>Travel medicine</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>Intensely clustered outbreak of visceral leishmaniasis (kala-azar) in a setting of seasonal migration in a village of Bihar, India</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-019-4719-3-d6b26cdd/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-019-4719-3-d6b26cdd/</guid>
    <pubDate>Mon, 06 Jan 2020 00:00:00 GMT</pubDate>
    <description>The outbreak demonstrates vulnerability in low-endemic areas and highlights gaps in case-finding, treatment delays, incomplete vector control coverage, and the role of social and economic determinants in kala-azar transmission. The findings underscore the need for a routine outbreak response framework within the elimination programme.</description>
    <category>Leishmaniasis</category>
    <category>Kala-azar</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Treatment</category>
    <category>Outbreak investigation</category>
  </item>
  <item>
    <title>The Burden of Typhoid and Paratyphoid in India: Systematic Review and Meta-analysis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0004616-5e37ce6d/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0004616-5e37ce6d/</guid>
    <pubDate>Fri, 15 Apr 2016 00:00:00 GMT</pubDate>
    <description>The findings indicate that typhoid remains a significant public health challenge in India despite apparent declines in prevalence, particularly among young children, and suggest that newly-licensed conjugate vaccines for infant immunization could address this burden, especially amid growing antimicrobial resistance.</description>
    <category>Paratyphoid fever</category>
    <category>Typhoid fever</category>
    <category>Typhoid and Paratyphoid fever</category>
    <category>Climate and environment</category>
    <category>Vaccination</category>
    <category>Antimicrobial resistance</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Coverage and Effectiveness of Kyasanur Forest Disease (KFD) Vaccine in Karnataka, South India, 2005–10</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0002025-c96b67be/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0002025-c96b67be/</guid>
    <pubDate>Thu, 24 Jan 2013 00:00:00 GMT</pubDate>
    <description>The findings indicate suboptimal vaccination uptake and reduced vaccine effectiveness in the field setting, underscoring the need to expand coverage and investigate reasons for the diminished protection reported here.</description>
    <category>Kyasanur Forest disease</category>
    <category>Vaccination</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Vaccine effectiveness</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>The Global Enteric Multicenter Study (GEMS): Impetus, Rationale, and Genesis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-cid-cis761-71642628/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-cid-cis761-71642628/</guid>
    <pubDate>Tue, 20 Nov 2012 00:00:00 GMT</pubDate>
    <description>The work addresses diarrheal disease, cited as one of the top two causes of young child mortality in the developing world, and aims to inform prioritization of water/sanitation, hygiene, and vaccine strategies.</description>
    <category>Gastroenteritis</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Case-control study</category>
  </item>
  <item>
    <title>Inapparent infections and cholera dynamics</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-nature07084-46e6c2cf/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-nature07084-46e6c2cf/</guid>
    <pubDate>Fri, 01 Aug 2008 00:00:00 GMT</pubDate>
    <description>The findings suggest that inapparent infections are central to interpreting cholera outbreak patterns and that environmental sources may be critical to sustaining endemicity, with implications for transmission theory and control strategies.</description>
    <category>Cholera</category>
    <category>Transmission dynamics</category>
    <category>Vaccine effectiveness</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
</channel>
</rss>
